Company: STAA
Filing Date: 2025-10-09
Form Type: DFAN14A
Source: 0001213900-25-097833
Chunk: 20

Company: STAAR SURGICAL CO
Filing Date: 2025-10-09
Form: DFAN14A
Chunk 20
---
 following statement
outlining its opposition of the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC):

We have been significant STAAR shareholders
for more than ten years and remain convicted in the significant value of the Company. The proposed sale of STAAR to Alcon for $28 per
share significantly undervalues the Company, especially when considering the STAAR Board of Directors' rejection of Alcon's previous offer
for $58 per share in cash only sixteen months ago.

With recent positive projections and
outlook released by management, we see no compelling reason to sell STAAR at this time. We are disappointed that the Board has pursued
this ill-advised transaction at a valuation that does not reflect the prospects of STAAR's business as a standalone company.

About

Defender Capital, an SEC-Registered Investment
Advisor, manages investment accounts – retirement accounts, non-retirement accounts, trusts, corporate accounts, donor-advised funds,
etc. – for individuals, families, and corporations. We take a research driven, long-term approach, investing in U.S. equities.

Contacts

ASC Advisors
Taylor Ingraham
tingraham@ascadvisors.com
203 992 1230

SOURCE Defender Capital

<div align='center'>Exhibit 4-1</div>